下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemENedaplatinCat. No.: HY-13700CAS No.: 95734-82-0Synonyms: NSC 375101D分式: CHNOPt分量: 303.18作靶点: DNA/RNA Synthesis作通路: Cell Cycle/DNA Damage储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 H2O : 13.6 m
2、g/mL (44.86 mM; Need ultrasonic and warming; DMSO can inactivate Nedaplatins activity)Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 3.2984 mL 16.4919 mL 32.9837 mL5 mM 0.6597 mL 3.2984 mL 6.5967 mL10 mM 0.3298 mL 1.6492 mL 3.2984 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。BIOLOGICAL ACTIVITY
3、物活性 Nedaplatin (NSC 375101D)铂衍物和DNA损伤剂。体外研究Nedaplatin (NSC 375101D, NDP) is a derivative of cisplatin which produced less nausea & vomiting andnephrotoxicity. the effect of NDP on the 7-ethyl-1-hydroxy-CPT (the active form of CPT-11)-induced inhibitoryeffect on DNA topoisomerase I was examined. The
4、topoisomerase I-inhibitory effect of 7-ethyl-1-hydroxy-CPT was enhanced 10-fold in the presence of Nedaplatin (NSC 375101D, NDP) at microgram/milliliter1/2 Master of Small Molecules 您边的抑制剂师www.MedChemEconcentrations 1. Nedaplatin (NSC 375101D, NDP) was developed as a second generation platinumcomple
5、x. Because it has greater antitumour activity and lower nephrotoxicity than cisplatin (CDDP). At thehigh-dose of Nedaplatin (NSC 375101D, NDP) in FN therapy, a reduction of tumour size and long-termtumour-free survival were frequently observed. The survival effect of the combinations of Nedaplatin (
6、NSC375101D, NDP) with 5-FU was superior to those of the combination of CDDP with 5-FU. In conclusion, thesequence-dependent antitumour efficacy and toxicity of the combination of NDP or CDDP with 5-FU wasdemonstrated in this study, and FN therapy appeared to be the most efficient regimen as a clinic
7、al therapy2.REFERENCES1. Kanzawa, F., et al., In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitoririnotecan and the mechanism of this interaction. Clin Cancer Res, 2001. 7(1): p. 202-9.2. Uchida, N., et al., Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with5-fluorouracil in an in vivo murine tumour model. Eur J Cancer, 1998. 34(11): p. 1796-801.McePdfHeightCaution: Product has not been fully validated for medical applications.For r
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 企业工作总结与技术创新应用
- 医院突发事件应急预案工作总结
- 反洗钱知识考试题库
- 企业产品总结
- 头晕护理教学查房
- 《论大数据时代个人信息的法律保护》
- 环境消防工作总结
- 生活部工作目标和计划(18篇)
- 物业项目经理年终工作总结结束语(21篇)
- 物业保安维修合同协议书(十七篇)
- 2024年福建泉州交通发展集团有限责任公司招聘笔试参考题库附带答案详解
- 食品安全主体责任
- 中国居民膳食指南(全)
- 高中生物 必修2《遗传与进化》遗传因子的发现 单元整体教学设计
- 2024安徽省兴泰融资担保集团限公司招聘4人高频考题难、易错点模拟试题(共500题)附带答案详解
- 四年级数学下册练习册
- 电动汽车的未来发展课件
- 2024年改革开放再迈新步伐
- 苯甲酸的生产工艺
- 商场类企业安全风险分级管控体系实施指南
- 安全生产治本攻坚三年行动方案解读(培训课件)
评论
0/150
提交评论